Novavax Inc
NVAX
$11.26-12.17%
End of day · as of Oct 17, 2026, 2:00 PM ET
Mkt cap
$1.09B
EV/Sales
0.98
P/E ratio
N/A
FY2025 Revenue
$1.12B
EPS (TTM)
$-1.35
Gross Margin (FY2025)
93.50%
Profit Margin (FY2025)
39.19%
Beta
2.77
Div yield
N/A
Sector
Healthcare
Novavax Inc (NVAX) is a biotechnology company listed on US.
Latest reported NVAX revenue for 2025-12-31 was $1.12B. Net income was $440.3M. Revenue was up 64.7% from 2024-12-31 to 2025-12-31. NVAX currently screens at market cap $1.09B.
Use this NVAX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NVAX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Novavax Inc (NVAX) is a biotechnology company in the Healthcare sector.
Latest cached Novavax Inc (NVAX) revenue for Dec 31, 2025 was $1.12B. Net income was $440.3M. Statements: https://lician.com/financials/nvax
Novavax Inc (NVAX) market capitalization is $1.09B on the latest cached snapshot.
Novavax Inc (NVAX) cached previous close $12.82; day range $11.26 – $12.71; volume 9,868,461. Session quote: https://lician.com/quote/nvax
Novavax Inc (NVAX) latest cached earnings event is "NVAX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NVAX filing is 8-K · Jun 23, 2026. Filings: https://lician.com/sec/nvax